Literature DB >> 13868721

Studies on autoantibodies in myasthenia gravis.

E H BEUTNER, E WITEBSKY, D RICKEN, R H ADLER.   

Abstract

Entities:  

Keywords:  ANTIBODIES; FLUORESCENT DYES; MYASTHENIA GRAVIS/immunology

Mesh:

Substances:

Year:  1962        PMID: 13868721

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  28 in total

1.  MYASTHENIA GRAVIS WITH HYPERGAMMAGLOBULINAEMIA AND ANTIBODIES.

Authors:  H J OOSTERHUIS; H VAN DER GELD; T E FELTKAMP; F PEETOOM
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-08       Impact factor: 10.154

2.  HEART MUSCLE ANTIBODIES IN RHEUMATIC FEVER AND OTHER DISEASES.

Authors:  E V HESS; C W FINK; A TARANTA; M ZIFF
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

3.  Immunohistochemical study of the ontogenetic development of smooth muscle in the mouse embryo.

Authors:  P Montagne; J Duheille
Journal:  Wilehm Roux Arch Dev Biol       Date:  1975-12

4.  The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.

Authors:  J Peers; B L McDonald; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

Review 5.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

6.  The effect of thymectomy, hemi-thymectomy and sham thymectomy on experimental myasthenia gravis in guinea-pigs.

Authors:  J R Kalden; W G Williamson; W J Irvine
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

7.  Studies on experimental autoimmune thymitis in guinea-pigs.

Authors:  J R Kalden; W G Williamson; R J Johnston; W J Irvine
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

8.  [On the impaired neuromuscular transmission in myasthenia gravis].

Authors:  P Kruckenberg; W Pontzen; R Sandweg; H Bauer
Journal:  Z Neurol       Date:  1971

9.  Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors.

Authors:  E H Beutner; M R Sepulveda; E V Barnett
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

10.  Antibodies against saline-soluble components of skeletal muscle in myasthenia gravis.

Authors:  A Komiyama; I Kamo; S Furukawa; S Akazawa; K Hirayama; E Satoyoshi
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.